Detalhe da pesquisa
1.
Lessons from a Recovering Academic.
Cell
; 165(5): 1043-1048, 2016 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27203106
Mostrar mais
Texto completo
Documentos relacionados
2.
Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
N Engl J Med
; 390(4): 338-345, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265645
3.
Research funders must join the fight for equal access to medicines.
Nature
; 626(7997): 7-8, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291143
4.
Citizens' views on prices of medicines reimbursed by the National Health Service: Findings from Italian online focus groups.
Health Expect
; 27(2): e14005, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38432872
5.
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.
JAMA
; 329(5): 386-392, 2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749334
6.
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists.
JAMA
; 330(7): 650-657, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505513
7.
The Myth of the Free Market for Pharmaceuticals.
N Engl J Med
; 390(16): 1448-1450, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38647106
8.
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands.
Value Health
; 25(1): 91-103, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031104
9.
Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? A Discrete Choice Experiment Among Dutch Healthcare Decision Makers.
Value Health
; 25(2): 222-229, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094795
10.
The default of 1998 and pharmaceutical market. Report I. The chronicle of disaster.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med
; 30(4): 683-691, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960302
11.
Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology.
Circulation
; 142(8): 790-798, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833519
12.
Medicare Overpayment for Outpatient Medication - A Supreme Court Ruling in Context.
N Engl J Med
; 388(3): 196-198, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648085
13.
Coverage and Pricing Recommendations of the French National Health Authority for Innovative Drugs: A Retrospective Analysis From 2014 to 2020.
Value Health
; 24(12): 1784-1791, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838276
14.
Toward Better Data Dashboards for US Drug Value Assessments.
Value Health
; 24(10): 1484-1489, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593172
15.
Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance.
Value Health
; 24(10): 1476-1483, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593171
16.
Does the separating of hospital revenue from drug sales reduce the burden on patients? Evidence from China.
Int J Equity Health
; 20(1): 12, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407503
17.
On the role of cost-effectiveness thresholds in healthcare priority setting.
Int J Technol Assess Health Care
; 37: e23, 2021 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491617
18.
Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
Int J Equity Health
; 19(1): 133, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762691
19.
One drug to treat many diseases: unlocking the economic trap of rare diseases.
Metab Brain Dis
; 35(8): 1237-1240, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926291
20.
Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil.
BMC Health Serv Res
; 20(1): 80, 2020 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32013963